Thyrocare, a diagnostic and preventive healthcare service provider in India, has signed a Business Transfer Agreement with Polo Labs Private to acquire their pathology diagnostic business.
The company in a press statement on Friday, said that this strategic acquisition significantly expands Thyrocare’s footprint in Northern India, reinforcing its position as a dominant player in the Indian diagnostic industry.
Polo Labs, headquartered in Punjab, operates 14 laboratories across Punjab, Haryana, and Himachal Pradesh. Their well-established network and regional expertise make them a valuable addition to Thyrocare’s operations.
The acquisition of Polo Labs aligns perfectly with Thyrocare's broader business strategy in the healthcare sector, which emphasises enhancing diagnostic capabilities and extending its reach across India. By integrating Polo Labs’ existing network with Thyrocare's advanced diagnostic infrastructure, the company aims to deliver improved service delivery, faster turnaround times, and unmatched patient convenience.
Rahul Guha, MD & CEO of Thyrocare Technologies & President of API Holdings, stated, "This strategic acquisition will enhance our diagnostic capabilities and service offerings, leveraging Polo Labs' existing widespread network in North India. We are committed to a seamless integration and look forward to the growth and innovation this acquisition will bring. Together, we will continue to provide exceptional diagnostic services to a broader client base."
_20241121132051_original_image_37.webp)
_20241121121207_original_image_9.webp)
_20241120184330_original_image_27.webp)